Neuroendocrine tumors future or investigational therapies
Neuroendocrine tumors Microchapters
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Future or Investigational Therapies
Therapies based on growth factor inhibitors are in the experimental stage. These inhibitors of epidermal growth factor receptors (EGFRs), of vascular endothelial growth factor receptors (VEGFRs), and of angiopoietin-related growth factor (AGF) include imatinib, sunitinib, temozolide, thalidomide, sorafenib, and panitumumab.